ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
| Autor: | Schnittger, S1, Eder, C1, Jeromin, S1, Alpermann, T1, Fasan, A1, Grossmann, V1, Kohlmann, A1, Illig, T2, Klopp, N2, Wichmann, H-E3, Kreuzer, K-A4, Schmid, C5, Staib, P6, Peceny, R7, Schmitz, N8, Kern, W1, Haferlach, C1, Haferlach, T1 |
|---|---|
| Zdroj: | Leukemia (08876924). Jan2013, Vol. 27 Issue 1, p82-91. 10p. 2 Diagrams, 4 Charts, 2 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|